Results 1 to 10 of about 3,775 (250)

Prosopis cineraria: A potential nootropic agent [PDF]

open access: bronzePharmaceutical Biology, 2012
Prosopis cineraria (L.) Druce (Leguminosae), a plant of the Thar Desert of India and Pakistan is used traditionally by local people for the treatment of memory disorders and to arrest wandering of the mind.The study includes scientific validation of P. cineraria for nootropic activity.
Bhawani Singh Bithu   +4 more
openalex   +3 more sources

Awareness on nootropic herbs among dental students Herbal nootropic agents

open access: diamondInternational Journal of Research in Pharmaceutical Sciences, 2020
Nootropics herb constitutes of compounds that enhance cognitive performance by increasing mental functions memory, creativity, motivation, and attention, eventually causing individuals to be many alerts and focused. These nootropic herbs tend to enhance brain performances. To assess the awareness on nootropic herbs among dental students.
Denesh Raj   +2 more
openalex   +2 more sources

Are CB1 receptor antagonists nootropic or cognitive impairing agents? [PDF]

open access: greenDrug Development Research, 2009
AbstractFor more than a decade, a considerable amount of research has examined the effects of rimonabant (SR 141716) and other CB1 receptor antagonists in both in vivo and in vitro models of learning and memory. In addition to its utility in determining whether the effects of drugs are mediated though a CB1 receptor mechanism of action, these ...
Stephen A. Varvel   +2 more
openalex   +3 more sources

Nootropic Agents Enhance the Recruitment of Fast GABAA Inhibition in Rat Neocortex [PDF]

open access: bronzeCerebral Cortex, 2004
It is widely believed that nootropic (cognition-enhancing) agents produce their therapeutic effects by augmenting excitatory synaptic transmission in cortical circuits, primarily through positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionate receptors (AMPARs).
Douglas S.F. Ling, Larry S. Benardo
openalex   +3 more sources

NOOTROPICS AGENTS: PHARMACEUTICAL ASPECT, COMMON EXAMPLES AND THEIR APPLICATIONS

open access: diamondJournal of Drug Delivery and Therapeutics, 2018
Nootropics compounds are one of the important categories of medicinal agents act as cognitive enhancers and neuroprotective. These agents mainly used to improve memory related functioning of brain. Nootropic compounds exhibited various neural activities and boost functioning of central nervous system including improvement of intellectual, memory and ...
Leena Sakhare Vitthalrao
openalex   +3 more sources

Potential nootropic agents, 4-alkoxy-2-(1-piperazinyl)quinazoline derivatives.

open access: bronzeChemical and Pharmaceutical Bulletin, 1991
A series of 4-alkoxy-2-(1-piperazinyl)quinazoline derivatives was synthesized and evaluated for its ability to reverse a scopolamine-induced learned impairment in a one-trial passive avoidance task (antiamnestic activity). 2-(4-Allyl-1-piperazinyl)-4-pentyloxyquinazoline (4) showed more potent antiamnestic activity than such reference compounds as ...
Misako Hori   +5 more
openalex   +4 more sources

Nootropic properties of a new combined cytoprotective agent

open access: closedAgeing & Longevity, 2022
Medicinal products of nootropic action, which have a positive effect on neurometabolism and normalize memory and intellectual functions, are an important component of complex pharmacotherapy for various neurological and cerebrovascular diseases. The aim of the work was an experimental study of the nootropic activity of the new combined drug Melarginin,
Liana Kuprash   +4 more
openalex   +2 more sources

Neuroprotective effects of a new nootropic agent Mitochondrin-2 [PDF]

open access: diamondFiziolohichnyĭ zhurnal, 2020
Khrystyna Dronska   +4 more
openalex   +2 more sources

Single- and Multiple-dose Pharmacokinetics of Nefiracetam, a New Nootropic Agent, in Healthy Volunteers

open access: closedJournal of Pharmacy and Pharmacology, 1992
Abstract The pharmacokinetic profile of nefiracetam (N-(2,6-dimethylphenyl)-2-(2-oxo-l-pyrrolidinyl)acetamide), a new nootropic agent, was studied in healthy Japanese male volunteers. Nefiracetam was administered orally at doses of 10–200 mg in the single-dose studies, and at doses of 200 mg three times a day for seven days in the ...
Yuko Fujimaki   +4 more
openalex   +3 more sources

Smart drugs among students – multidimensional view on present ways of cognitive enhancement

open access: yesJournal of Education, Health and Sport, 2023
Background: Nootropic drugs, at the beginning of their career, were used in the treatment of diseases such as attention deficit hyperactivity disorder (ADHD), Alzheimer's disease and narcolepsy.
Piotr Pisera   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy